Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11712468 CD70 combination therapy

Overview Structured Data Issues Contributors Activity

Is a

0

Date Filed

December 18, 2019

0

Date of Patent

August 1, 2023

0

Patent Application Number

16719220

0

Patent Citations

US Patent 7723477 Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth

0

US Patent 8324361 Nucleic acid molecules encoding soluble frizzled (FZD) receptors

0

US Patent 8455622 Variant target binding agents and uses thereof

0

US Patent 8507442 Methods of use for an antibody against human frizzled receptors 1, 2. 5, 7 or 8

0

US Patent 8535678 Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders

0

US Patent 8552156 Anti-TIM-3 antibody

0

US Patent 8604052 Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof

0

US Patent 8647623 Method for treatment of blood tumor using anti-TIM-3 antibody

0

US Patent 8663642 Anti-CD70 antibody-drug conjugates and their use for the treatment and prevention of cancer and immune disorders

0

US Patent 8765913 Human frizzled (FZD) receptor polypeptides and methods of use thereof for treating cancer and inhibiting growth of tumor cells

0

•••

Patent Citations Received

US Patent 11945785 Pyrazine compounds as inhibitors of FLT3

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

0

Patent Primary Examiner

Laura B Goddard

0

CPC Code

0

0

0

0

0

0

0

0

0

0

Find more entities like US Patent 11712468 CD70 combination therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.